Skip to content
MARKETS
USD/NGN
1,348.05
▲ 0.43%
GBP/NGN
1,778.66
▲ 0.23%
EUR/NGN
1,484.42
▲ 0.26%
BRENT
93.46
▼ 2.48%
GOLD
3,861.9
▼ 0.63%
COCOA
5,207
▼ 1.01%
BITCOIN
64,723
▼ 0.91%
ETHER
1,828
▼ 0.40%
S&P 500
7,484.93
▼ 1.01%
FTSE 100
10,901.21
▼ 0.01%
US 10Y
5.13%
▼ 2bp
USD/NGN
1,348.05
▲ 0.43%
GBP/NGN
1,778.66
▲ 0.23%
EUR/NGN
1,484.42
▲ 0.26%
BRENT
93.46
▼ 2.48%
GOLD
3,861.9
▼ 0.63%
COCOA
5,207
▼ 1.01%
BITCOIN
64,723
▼ 0.91%
ETHER
1,828
▼ 0.40%
S&P 500
7,484.93
▼ 1.01%
FTSE 100
10,901.21
▼ 0.01%
US 10Y
5.13%
▼ 2bp
Today’s paper · Nigeria
The Brief · listen
Markets Reporters
Energy · Money · Capital
Search stories or ask a question
⌘K
My feed
Latest stories
Menu
MR
Home
Latest
FEATURED
TOP STORIES
Energy
Economy
Stocks
Money
Technology
Thinkpiece
Agriculture
Data
LIVE
MR Terminal →
Home
Markets
Search
Listen
Saved
GlaxoSmithKline Consumer Nigeria | Markets Reporters
Topic
GlaxoSmithKline Consumer Nigeria
Follow
GlaxoSmithKline Consumer Nigeria
2 stories
Topics
GlaxoSmithKline Consumer Nigeria
FEATURED
GSK Nigeria reports N238.07m quarterly loss
GlaxoSmithKline Consumer Nigeria Plc has reported a loss after tax of N238.07 million for the quarter ended Mar. 31, 2021, compared with a profit after tax of N113.47 million in the same period of last year.
Markets Reporters ·
27 Apr 2021
Latest
GSK Nigeria’s profit falls 32.15% amid COVID-19 pandemic
5 Apr 2021